LY3154885
LY3154885 is an orally active dopamine D1 receptor positive allosteric modulator (PAM) . LY3154885 has an improved agent-agent interactions (DDI) risk profile[1].
Product Specifications
CAS Number
[2379422-72-5]
UNSPSC
12352005
Target
Dopamine Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/ly3154885.html
Solubility
10 mM in DMSO
Smiles
CN1N=CC(C2=CC=CC3=C2C[C@H](CO)N(C(CC4=C(Cl)C=CC=C4Cl)=O)[C@H]3C)=C1
Molecular Formula
C23H23Cl2N3O2
Molecular Weight
444.35
References & Citations
[1]Junliang Hao, et al. Synthesis and Preclinical Characterization of LY3154885, a Human Dopamine D1 Receptor Positive Allosteric Modulator with an Improved Nonclinical Drug-Drug Interaction Risk Profile. J Med Chem. 2022 Mar 10;65 (5) :3786-3797.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 1
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
034151-FITC 200 µL
CP013, NT (C16orf13, UPF0585 protein C16orf13) (FITC) discontinued
Ask
View Details 
bsm-61434R-PerCP-Cy5.5 100 µL
Dopamine Transporter Recombinant Antibody, PerCP-Cy5.5 Conjugated
Ask
View Details 
038714-ML750 100 µL
MYBPC1, ID (MYBPC1, MYBPCS, Myosin-binding protein C, slow-type, C-protein, skeletal muscle slow isoform) (MaxLight 750) discontinued
Ask
View Details